Search Results 1031-1040 of 17307 for colitis

1. A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional Therapies But Have Not Failed Biologic Therapy - Mayo Clinic

   ... infection or must be asymptomatic for 14 days from a potential exposure;; fulminant colitis,; toxic megacolon;; or any other manifestation that might require ...

2. An Integrated Metagenomics and Immunoproteomics Study of the Role of Microbiome in Pouchitis Development - Mayo Clinic

   Confirmed diagnosis of ulcerative colitis and/or dysplasia. Subjects who are undergoing or have undergone a proctocolectomy with ileal pouch anal ...

3. Tremelimumab-Actl (Intravenous Route) Before Using - Mayo Clinic

   Adrenal gland problems or; Diabetes or; Immune system problems (eg, Crohn's disease, ulcerative colitis, lupus) or; Kidney problems or; Nervous system problems ...

4. Infliximab (Intravenous Route) Before Using - Mayo Clinic

   ... ulcerative colitis in children 6 years of age and older. However, safety and ... Aspergillosis (fungus infection), history of or; Blastomycosis (fungus ...

5. Polyethylene Glycol 3350 And Electrolytes (Oral Route) Before Using - Mayo Clinic

   Inflammatory bowel disease or; Kidney disease or; Seizures, history of or; Trouble swallowing or; Ulcerative colitis, active and severe—Use with caution. May ...

6. Interferon Alfa-2b (Injection Route) Before Using - Mayo Clinic

   Bone marrow problems or; Bowel problems (eg, colitis) or; Depression or mental illness, history of or; Diabetes or; Diabetic retinopathy (diabetic eye problem) ...

7. Publications - Shannon P. Sheedy, M.D. - Mayo Clinic

   Clinical and Radiographic Characteristics in Segmental Colitis Associated with Diverticulosis, and Crohn's Disease Gastro Hep Advances. 2024. Bach CR, Sheedy SP ...

8. Mercaptopurine (Oral Route) Precautions - Mayo Clinic

   Some teenagers and young adults with Crohn's disease or ulcerative colitis developed a rare type of cancer called hepatosplenic T-cell lymphoma (HSTCL).

9. A Study of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease - Mayo Clinic

   ... bowel resection within 12 weeks of entry into the study. Subject has a diagnosis of UC, indeterminate colitis, radiation colitis, or ischemic colitis, or ...

10. A Study of How the Natural Bacteria of the Intestines Can Affect Weight Loss Success - Mayo Clinic

    History of Ulcerative colitis, Crohn's disease or Celiac sprue; Not exclude, but note patients taking PPI's or statins or oral hypoglycemics. Participating ...